LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
15 08 2019
Historique:
received: 06 04 2018
accepted: 19 12 2018
pubmed: 18 1 2019
medline: 4 12 2019
entrez: 18 1 2019
Statut: ppublish

Résumé

Endothelial lipase (LIPG) is a cell surface associated lipase that displays phospholipase A1 activity towards phosphatidylcholine present in high-density lipoproteins (HDL). LIPG was recently reported to be expressed in breast cancer and to support proliferation, tumourigenicity and metastasis. Here we show that severe oxidative stress leading to AMPK activation triggers LIPG upregulation, resulting in intracellular lipid droplet accumulation in breast cancer cells, which supports survival. Neutralizing oxidative stress abrogated LIPG upregulation and the concomitant lipid storage. In human breast cancer, high LIPG expression was observed in a limited subset of tumours and was significantly associated with shorter metastasis-free survival in node-negative, untreated patients. Moreover, expression of PLIN2 and TXNRD1 in these tumours indicated a link to lipid storage and oxidative stress. Altogether, our findings reveal a previously unrecognized role for LIPG in enabling oxidative stress-induced lipid droplet accumulation in tumour cells that protects against oxidative stress, and thus supports tumour progression.

Identifiants

pubmed: 30653260
doi: 10.1002/ijc.32138
pmc: PMC6618071
doi:

Substances chimiques

Lipids 0
Lipoproteins, HDL 0
LIPG protein, human EC 3.1.1.3
Lipase EC 3.1.1.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

901-915

Informations de copyright

© 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

Biochem Soc Trans. 2003 Feb;31(Pt 1):202-6
pubmed: 12546685
Cancer Res. 2005 Feb 1;65(3):840-9
pubmed: 15705882
Nature. 2012 May 09;485(7400):661-5
pubmed: 22660331
Clin Cancer Res. 2012 May 1;18(9):2695-703
pubmed: 22351685
J Lipid Res. 2002 Nov;43(11):1763-9
pubmed: 12401876
J Biol Chem. 1999 Mar 19;274(12):7936-40
pubmed: 10075689
FEBS J. 2012 Aug;279(15):2610-23
pubmed: 22621751
Prog Lipid Res. 2013 Oct;52(4):585-9
pubmed: 24001676
Cancer Res. 2008 Jul 1;68(13):5405-13
pubmed: 18593943
Biostatistics. 2010 Apr;11(2):242-53
pubmed: 20097884
Cell Cycle. 2012 Apr 1;11(7):1383-92
pubmed: 22421146
Biochim Biophys Acta. 2012 Jul;1821(7):1003-11
pubmed: 23075452
Cell Metab. 2012 Mar 7;15(3):279-91
pubmed: 22405066
Elife. 2018 Jan 19;7:
pubmed: 29350614
Mol Cell Biol. 2009 Aug;29(16):4495-507
pubmed: 19528227
Chem Biol Interact. 2016 Nov 25;259(Pt B):211-222
pubmed: 27067293
EMBO J. 2005 Jan 12;24(1):170-9
pubmed: 15616590
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14476-81
pubmed: 22908275
Nat Genet. 1999 Apr;21(4):424-8
pubmed: 10192396
Cell Rep. 2014 Oct 9;9(1):349-365
pubmed: 25263561
Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5
pubmed: 23193258
Biochim Biophys Acta. 2015 May;1853(5):918-28
pubmed: 25655664
Mol Cancer Ther. 2011 Mar;10(3):427-36
pubmed: 21282354
Cancer Res. 2006 Jun 15;66(12):5977-80
pubmed: 16778164
Histochem Cell Biol. 2001 Jul;116(1):63-8
pubmed: 11479724
Dev Cell. 2015 Mar 23;32(6):678-92
pubmed: 25752962
J Lipid Res. 2005 Jul;46(7):1517-25
pubmed: 15834125
Biochim Biophys Acta Gen Subj. 2017 Mar;1861(3):673-682
pubmed: 27939617
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
Cancer Cell. 2006 Jul;10(1):25-38
pubmed: 16843263
Cell. 2015 Oct 8;163(2):340-53
pubmed: 26451484
Breast Cancer Res. 2010;12(3):R44
pubmed: 20584310
Biochim Biophys Acta. 2012 Sep;1821(9):1256-68
pubmed: 22178194
Cancer Res. 2000 Jan 15;60(2):213-8
pubmed: 10667561
J Biol Chem. 2002 Sep 6;277(36):32571-7
pubmed: 12065578
Biochem Biophys Res Commun. 2010 Jul 30;398(3):495-9
pubmed: 20599696
Nat Commun. 2016 Apr 05;7:11199
pubmed: 27045898
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Lipid Res. 2005 May;46(5):977-87
pubmed: 15722560
Sci Adv. 2016 May 27;2(5):e1600200
pubmed: 27386546
Free Radic Biol Med. 2017 Mar;104:144-164
pubmed: 28088622

Auteurs

Cristina Cadenas (C)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Sonja Vosbeck (S)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Karolina Edlund (K)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Katharina Grgas (K)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Katrin Madjar (K)

Department of Statistics, TU Dortmund University, Dortmund, Germany.

Birte Hellwig (B)

Department of Statistics, TU Dortmund University, Dortmund, Germany.

Alshaimaa Adawy (A)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Annika Glotzbach (A)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Joanna D Stewart (JD)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Michaela S Lesjak (MS)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Dennis Franckenstein (D)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Maren Claus (M)

Department of Immunology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Heiko Hayen (H)

Department of Analytical Chemistry, Institute of Inorganic and Analytical Chemistry, University of Münster, Münster, Germany.

Alexander Schriewer (A)

Department of Analytical Chemistry, Institute of Inorganic and Analytical Chemistry, University of Münster, Münster, Germany.

Kathrin Gianmoena (K)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Sonja Thaler (S)

European Center for Angioscience (ECAS), Medical Faculty Mannheim of the University of Heidelberg, Tridomus C, Mannheim, Germany.

Marcus Schmidt (M)

Department of Obstetrics and Gynecology, University Hospital Mainz, Mainz, Germany.

Patrick Micke (P)

Department of Immunology Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Fredrik Pontén (F)

Department of Immunology Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Adil Mardinoglu (A)

Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.

Cheng Zhang (C)

Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.

Heiko U Käfferlein (HU)

Center of Toxicology, Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Institute of the Ruhr University Bochum, Bochum, Germany.

Carsten Watzl (C)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Saša Frank (S)

Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.

Jörg Rahnenführer (J)

Department of Statistics, TU Dortmund University, Dortmund, Germany.

Rosemarie Marchan (R)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Jan G Hengstler (JG)

Department of Toxicology, Leibniz-Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Dortmund, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH